platinum has been researched along with nedaplatin in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eguchi, K; Ohe, Y; Ohmori, T; Saijo, N; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
| Hirabayashi, K; Oguma, T; Okada, E; Shimamura, K | 1 |
| Fujita, H; Okamoto, M; Takao, A | 1 |
| Majima, H | 1 |
| Ishihara, H; Itamochi, H; Kanamori, Y; Kigawa, J; Minagawa, Y; Terakawa, N | 1 |
| Akaboshi, M; Kawai, K; Kinashi, Y; Masunaga, S; Ono, K | 1 |
| Ishibashi, T; Oguma, T; Yano, Y | 1 |
| Kano, M; Matsui, T | 1 |
| Ito, K; Nagase, S; Nemoto, K; Niikura, H; Ogawa, Y; Takano, T; Yaegashi, N; Yoshinaga, K | 1 |
| Hamada, Y; Hayakawa, K; Kotani, A; Kusu, F; Naitoh, H; Niibe, Y; Takayanagi, R; Tsunoda, S; Unno, N; Yago, K; Yamada, Y | 1 |
| Kotani, A; Kusu, F; Otsuki, Y | 1 |
| Galanski, MS; Jakupec, MA; Jensen, F; Keppler, BK; Roller, A; Varbanov, HP | 1 |
| Galanski, MS; Göschl, S; Jakupec, MA; Keppler, BK; Theiner, S; Varbanov, HP | 1 |
| Blanchard, P; Tao, Y | 1 |
| DeYonker, NJ; Duplanty, M; Khan, S; Lozano, HC; Mirsaleh-Kohan, N; Morris, TJ; Nguyen, T; Rostovtsev, YV; Torres, M | 1 |
1 trial(s) available for platinum and nedaplatin
| Article | Year |
|---|---|
Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Organoplatinum Compounds; Platinum; Radioisotope Teletherapy; Uterine Cervical Neoplasms | 2007 |
14 other study(ies) available for platinum and nedaplatin
| Article | Year |
|---|---|
Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.
Topics: Antineoplastic Agents; Biological Assay; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Humans; Lung Neoplasms; Organoplatinum Compounds; Platinum; Tumor Cells, Cultured | 1991 |
[Pharmacokinetics of cis-diammine (glycolato) platinum (254-S), a new platinum antitumor agent, following an intravenous and intraperitoneal infusion bioactive platinum concentration profile].
Topics: Aged; Antineoplastic Agents; Biological Assay; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Middle Aged; Organoplatinum Compounds; Peritonitis; Platinum; Stomach Neoplasms; Uterine Cervical Neoplasms | 1990 |
[Pharmacokinetics of new cisplatin analogues in experimental animals].
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Mice; Organoplatinum Compounds; Platinum; Protein Binding; Rabbits; Sarcoma 180; Tissue Distribution | 1989 |
[Present status of cisplatin (CDDP) analogues in Japan].
Topics: Antineoplastic Agents; Carboplatin; Chemical Phenomena; Chemistry; Cisplatin; Female; Humans; Kidney; Leukopenia; Nervous System; Organoplatinum Compounds; Platinum; Protein Binding; Thrombocytopenia | 1989 |
Platinum concentrations in uterus and serum after internal iliac arterial infusion of platinum compounds in rabbits.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Female; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Jugular Veins; Organoplatinum Compounds; Platinum; Rabbits; Uterus | 1995 |
Relationship between cell-killing efficiency and number of platinum atoms binding to DNA, RNA, and protein molecules in HeLa cells treated with cis-diamine(glycolato)platinum(II).
Topics: Antineoplastic Agents; Cell Survival; DNA, Neoplasm; Dose-Response Relationship, Drug; HeLa Cells; Humans; Neoplasm Proteins; Organoplatinum Compounds; Platinum; RNA, Neoplasm; Structure-Activity Relationship | 1996 |
Population pharmacokinetics of platinum after nedaplatin administration and model validation in adult patients.
Topics: Adult; Antineoplastic Agents; Female; Humans; Male; Organoplatinum Compounds; Platinum; Retrospective Studies | 2003 |
[Pharmacodynamics of tongue tissue and plasma after intraarterial infusion of cis-diammine glycolato platinum (CDGP)].
Topics: Animals; Antineoplastic Agents; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Organoplatinum Compounds; Platinum; Rats; Rats, Inbred F344; Tissue Distribution; Tongue | 2004 |
Initial analysis of relationship between plasma platinum concentration and hematological adverse reaction associated with weekly chemotherapy using nedaplatin in combination with radiotherapy for cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Leukopenia; Middle Aged; Organoplatinum Compounds; Pilot Projects; Platinum; Thrombocytopenia; Uterine Cervical Neoplasms | 2010 |
Capillary liquid chromatography with UV detection using N,N-diethyl dithiocarbamate for determining platinum-based antitumor drugs in plasma.
Topics: Animals; Antineoplastic Agents; Carboplatin; Chromatography, High Pressure Liquid; Cisplatin; Injections, Intraperitoneal; Male; Organoplatinum Compounds; Platinum; Rats; Rats, Wistar; Spectrophotometry, Ultraviolet; Thiocarbamates | 2012 |
Theoretical investigations and density functional theory based quantitative structure-activity relationships model for novel cytotoxic platinum(IV) complexes.
Topics: Antineoplastic Agents; Carboplatin; Cell Line, Tumor; Cisplatin; Coordination Complexes; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Ethylamines; Ethylenediamines; Humans; Models, Molecular; Molecular Conformation; Organoplatinum Compounds; Oxaliplatin; Platinum; Quantitative Structure-Activity Relationship; Thermodynamics | 2013 |
The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Biological Transport; Carboplatin; Cell Line, Tumor; Cell Survival; Cisplatin; Cold Temperature; Coordination Complexes; Glucose; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Ligands; Oligomycins; Organoplatinum Compounds; Oxidation-Reduction; Platinum; Prodrugs; Structure-Activity Relationship | 2016 |
Nedaplatin in nasopharyngeal cancer: the rebirth of platinum salts?
Topics: Antineoplastic Agents; Chemoradiotherapy; Cisplatin; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Platinum; Salts | 2018 |
Raman and Infrared Studies of Platinum-Based Drugs: Cisplatin, Carboplatin, Oxaliplatin, Nedaplatin, and Heptaplatin.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Malonates; Models, Chemical; Molecular Conformation; Organoplatinum Compounds; Oxaliplatin; Platinum; Quantum Theory; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Stereoisomerism; Vibration | 2018 |